AIMS1: Effect of tACS Stimulation on Alpha Oscillations

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT03178344
Collaborator
National Institutes of Health (NIH) (NIH), National Institute of Mental Health (NIMH) (NIH)
20
1
2
3.1
6.4

Study Details

Study Description

Brief Summary

Transcranial Alternating Current Stimulation (tACS) is one method that has been demonstrated to enhance alpha oscillations in healthy participants by applying weak electrical currents to the scalp to modulate rhythmic brain activity patterns. This study will involve tACS-induced frontal alpha oscillations, EEG recordings, and other physiological and biological measures.

Condition or Disease Intervention/Treatment Phase
  • Device: XCSITE100 Stimulator tACS
  • Device: XCSITE100 Stimulator Sham
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Each participant will receive sham stimulation or 10 Hz tACS stimulation at two separate sessions. The order will be randomized (ie, half the participants will receive sham stimulation at the first session and 10 Hz tACS stimulation at the second session, and the other half will receive 10 Hz tACS stimulation at the first session and sham stimulation at the second session).Each participant will receive sham stimulation or 10 Hz tACS stimulation at two separate sessions. The order will be randomized (ie, half the participants will receive sham stimulation at the first session and 10 Hz tACS stimulation at the second session, and the other half will receive 10 Hz tACS stimulation at the first session and sham stimulation at the second session).
Masking:
Double (Participant, Investigator)
Masking Description:
This study will follow a double-blind experimental design, so neither the participant nor the experimenter will know what kind of stimulation the participant is receiving at what session. A separate unblinded monitor, who will not interact with the participants, will be responsible for creating the stimulation codes for each session.
Primary Purpose:
Basic Science
Official Title:
Rational Optimization of tACS for Targeting Thalamo-Cortical Oscillations (Experiment 2)
Actual Study Start Date :
Aug 1, 2017
Actual Primary Completion Date :
Nov 4, 2017
Actual Study Completion Date :
Nov 4, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sham Stimulation, then Alpha Stimulation

Participants receive sham stimulation at the first session, followed by a 5-9 day washout period and alpha stimulation at the second session. Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham. Participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes. tACS stimulation is delivered using the XCSITE100 Stimulator tACS.

Device: XCSITE100 Stimulator tACS
Transcranial alternating current stimulation (tACS) is a method of noninvasive brain stimulation in which weak electrical current are applied to the scalp in a sine wave pattern to induce cortical oscillations at the frequency at which they are applied.
Other Names:
  • tACS
  • Device: XCSITE100 Stimulator Sham
    The participant will receive up to one minute of tACS stimulation until the stimulation fades. Sham stimulation mimics the skin sensations a participant would experience during a tACS session.
    Other Names:
  • Sham tACS
  • Experimental: Alpha Stimulation, then Sham Stimulation

    Participants receive alpha stimulation at the first session, followed by a 5-9 day washout period and sham stimulation at the second session. Participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes. tACS stimulation is delivered using the XCSITE100 Stimulator tACS. Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham.

    Device: XCSITE100 Stimulator tACS
    Transcranial alternating current stimulation (tACS) is a method of noninvasive brain stimulation in which weak electrical current are applied to the scalp in a sine wave pattern to induce cortical oscillations at the frequency at which they are applied.
    Other Names:
  • tACS
  • Device: XCSITE100 Stimulator Sham
    The participant will receive up to one minute of tACS stimulation until the stimulation fades. Sham stimulation mimics the skin sensations a participant would experience during a tACS session.
    Other Names:
  • Sham tACS
  • Outcome Measures

    Primary Outcome Measures

    1. Salivary Alpha Amylase [Before and after 40-minute stimulation at each session.]

      Change after stimulation

    2. Salivary Cortisol [Before and after 40 minutes of stimulation]

      Change before and after stimulation

    Secondary Outcome Measures

    1. Heart Rate Variability [Before and after 40-minute stimulation at each session.]

      Change in the ratio between the power in low frequency band and the power in high frequency band. As this outcome variable is a ratio between two items that are measured in microvolt^2, the ratio does not have a unit of measure.

    2. Percent Change in Respiration [Before and after 40-minute stimulation at each session.]

      Respiration rate, measured via a belt placed around the participant's abdomen as breaths per second.

    3. Electroencephalogram (EEG) [Before and after 40-minute stimulation at each session.]

      The investigators will compare alpha oscillation power from resting-state EEG recordings before and after stimulation/sham at each session.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Ages 18-65

    • Capacity to understand all relevant risks and potential benefits of the study (informed consent)

    • Negative pregnancy test for female participants

    Exclusion Criteria:
    • History of major neurological or psychiatric illness, including epilepsy

    • Medication use associated with neurological or psychiatric illnesses

    • Currently undergoing counseling or psychotherapy treatment for depression, anxiety, eating disorders, PTSD or other behavioral conditions

    • First degree relative (parent, sibling, child) with major neurological or psychiatric illness

    • Prior brain surgery

    • Major head injury

    • Any brain devices/implants (including cochlear implants and aneurysm clips)

    • Braids or other hair styling that prevents direct access to the scalp (if removal not possible)

    • Skin allergies or very sensitive skin

    • Pregnant or nursing females

    • Failure to pass a urinary drug test at the first session

    • Use of hormonal birth control or supplements in the past two weeks

    • Non English speakers

    • Cardiovascular disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of North Carolina Chapel Hill Chapel Hill North Carolina United States 27514

    Sponsors and Collaborators

    • University of North Carolina, Chapel Hill
    • National Institutes of Health (NIH)
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Flavio Frohlich, PhD, University of North Carolina, Chapel Hill

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    University of North Carolina, Chapel Hill
    ClinicalTrials.gov Identifier:
    NCT03178344
    Other Study ID Numbers:
    • 16-1911a
    • R01MH111889-01
    First Posted:
    Jun 6, 2017
    Last Update Posted:
    Feb 26, 2019
    Last Verified:
    Feb 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Sham Stimulation, Then Alpha Stimulation Alpha Stimulation, Then Sham Stimulation
    Arm/Group Description Participants will receive sham stimulation at the first session. Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham. Then, participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes at the first session. tACS stimulation is delivered using the XCSITE100 Stimulator tACS. XCSITE100 Stimulator Sham: The participant will receive up to one minute of tACS stimulation until the stimulation fades. Sham stimulation mimics the skin sensations a participant would experience during a tACS session. Participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes at the first session. tACS stimulation is delivered using the XCSITE100 Stimulator tACS. Then, participants will receive sham stimulation at the second session. Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham. XCSITE100 Stimulator tACS: Transcranial alternating current stimulation (tACS) is a method of noninvasive brain stimulation in which weak electrical current are applied to the scalp in a sine wave pattern to induce cortical oscillations at the frequency at which they are applied.
    Period Title: First Session
    STARTED 10 10
    COMPLETED 10 10
    NOT COMPLETED 0 0
    Period Title: First Session
    STARTED 10 10
    COMPLETED 10 10
    NOT COMPLETED 0 0
    Period Title: First Session
    STARTED 10 10
    COMPLETED 10 10
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title Overall Group (Both Sham and Alpha Stimulation)
    Arm/Group Description Participants received sham stimulation at one session and alpha stimulation at the other in a randomized order. Sessions were separated by 5-9 days.
    Overall Participants 20
    Age (Count of Participants)
    <=18 years
    0
    0%
    Between 18 and 65 years
    20
    100%
    >=65 years
    0
    0%
    Sex: Female, Male (Count of Participants)
    Female
    5
    25%
    Male
    15
    75%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    Asian
    4
    20%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    Black or African American
    4
    20%
    White
    11
    55%
    More than one race
    1
    5%
    Unknown or Not Reported
    0
    0%

    Outcome Measures

    1. Primary Outcome
    Title Salivary Alpha Amylase
    Description Change after stimulation
    Time Frame Before and after 40-minute stimulation at each session.

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Sham Stimulation Alpha Stimulation
    Arm/Group Description Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham. XCSITE100 Stimulator Sham: The participant will receive up to one minute of tACS stimulation until the stimulation fades. Sham stimulation mimics the skin sensations a participant would experience during a tACS session. Participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes. tACS stimulation is delivered using the XCSITE100 Stimulator tACS. XCSITE100 Stimulator tACS: Transcranial alternating current stimulation (tACS) is a method of noninvasive brain stimulation in which weak electrical current are applied to the scalp in a sine wave pattern to induce cortical oscillations at the frequency at which they are applied.
    Measure Participants 20 20
    Mean (Standard Deviation) [log-normalized percent change of U/mL]
    0.00695
    (0.196)
    0.03055
    (0.188)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Sham Stimulation, Alpha Stimulation
    Comments
    Type of Statistical Test Equivalence
    Comments ANOVA
    Statistical Test of Hypothesis p-Value 0.70
    Comments P value threshold is 0.05
    Method ANOVA
    Comments
    2. Primary Outcome
    Title Salivary Cortisol
    Description Change before and after stimulation
    Time Frame Before and after 40 minutes of stimulation

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Sham Stimulation Alpha Stimulation
    Arm/Group Description Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham. XCSITE100 Stimulator Sham: The participant will receive up to one minute of tACS stimulation until the stimulation fades. Sham stimulation mimics the skin sensations a participant would experience during a tACS session. Participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes. tACS stimulation is delivered using the XCSITE100 Stimulator tACS. XCSITE100 Stimulator tACS: Transcranial alternating current stimulation (tACS) is a method of noninvasive brain stimulation in which weak electrical current are applied to the scalp in a sine wave pattern to induce cortical oscillations at the frequency at which they are applied.
    Measure Participants 20 20
    Mean (Standard Deviation) [log-normalized percent change µg/dL]
    -0.0551
    (0.168)
    -0.0702
    (0.164)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Sham Stimulation, Alpha Stimulation
    Comments
    Type of Statistical Test Equivalence
    Comments ANOVA
    Statistical Test of Hypothesis p-Value 0.71
    Comments P value threshold is 0.05.
    Method ANOVA
    Comments
    3. Secondary Outcome
    Title Heart Rate Variability
    Description Change in the ratio between the power in low frequency band and the power in high frequency band. As this outcome variable is a ratio between two items that are measured in microvolt^2, the ratio does not have a unit of measure.
    Time Frame Before and after 40-minute stimulation at each session.

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Sham Stimulation Alpha Stimulation
    Arm/Group Description Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham. XCSITE100 Stimulator Sham: The participant will receive up to one minute of tACS stimulation until the stimulation fades. Sham stimulation mimics the skin sensations a participant would experience during a tACS session. Participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes. tACS stimulation is delivered using the XCSITE100 Stimulator tACS. XCSITE100 Stimulator tACS: Transcranial alternating current stimulation (tACS) is a method of noninvasive brain stimulation in which weak electrical current are applied to the scalp in a sine wave pattern to induce cortical oscillations at the frequency at which they are applied.
    Measure Participants 20 20
    Mean (Standard Deviation) [log-normalized percent change]
    1.599
    (3.33)
    0.308
    (3.70)
    4. Secondary Outcome
    Title Percent Change in Respiration
    Description Respiration rate, measured via a belt placed around the participant's abdomen as breaths per second.
    Time Frame Before and after 40-minute stimulation at each session.

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Sham Stimulation Alpha Stimulation
    Arm/Group Description Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham. XCSITE100 Stimulator Sham: The participant will receive up to one minute of tACS stimulation until the stimulation fades. Sham stimulation mimics the skin sensations a participant would experience during a tACS session. Participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes. tACS stimulation is delivered using the XCSITE100 Stimulator tACS. XCSITE100 Stimulator tACS: Transcranial alternating current stimulation (tACS) is a method of noninvasive brain stimulation in which weak electrical current are applied to the scalp in a sine wave pattern to induce cortical oscillations at the frequency at which they are applied.
    Measure Participants 20 20
    Mean (Standard Deviation) [Percent change in breaths per second]
    -0.0075
    (0.076)
    0.0325
    (0.093)
    5. Secondary Outcome
    Title Electroencephalogram (EEG)
    Description The investigators will compare alpha oscillation power from resting-state EEG recordings before and after stimulation/sham at each session.
    Time Frame Before and after 40-minute stimulation at each session.

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Sham Stimulation Alpha Stimulation
    Arm/Group Description Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham. XCSITE100 Stimulator Sham: The participant will receive up to one minute of tACS stimulation until the stimulation fades. Sham stimulation mimics the skin sensations a participant would experience during a tACS session. Participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes. tACS stimulation is delivered using the XCSITE100 Stimulator tACS. XCSITE100 Stimulator tACS: Transcranial alternating current stimulation (tACS) is a method of noninvasive brain stimulation in which weak electrical current are applied to the scalp in a sine wave pattern to induce cortical oscillations at the frequency at which they are applied.
    Measure Participants 20 20
    Mean (Standard Deviation) [percent change of uV^2/Hz]
    -0.0087
    (0.0360)
    0.0114
    (0.0752)

    Adverse Events

    Time Frame From first session until completion of second session for each participant, for a total of 7-11 days (including both session days and 5-9 days of washout).
    Adverse Event Reporting Description
    Arm/Group Title Sham Stimulation Alpha Stimulation
    Arm/Group Description Sham Stimulation mimics the physical effects of stimulation, with up to one minute of stimulation during the session. Sham stimulation is delivered using the XCSITE100 Stimulator Sham. XCSITE100 Stimulator Sham: The participant will receive up to one minute of tACS stimulation until the stimulation fades. Sham stimulation mimics the skin sensations a participant would experience during a tACS session. Participants will receive 2 mA of alternating current stimulation at a frequency of 10 Hz for 40 minutes. tACS stimulation is delivered using the XCSITE100 Stimulator tACS. XCSITE100 Stimulator tACS: Transcranial alternating current stimulation (tACS) is a method of noninvasive brain stimulation in which weak electrical current are applied to the scalp in a sine wave pattern to induce cortical oscillations at the frequency at which they are applied.
    All Cause Mortality
    Sham Stimulation Alpha Stimulation
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/20 (0%) 0/20 (0%)
    Serious Adverse Events
    Sham Stimulation Alpha Stimulation
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/20 (0%) 0/20 (0%)
    Other (Not Including Serious) Adverse Events
    Sham Stimulation Alpha Stimulation
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/20 (0%) 0/20 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Jhana Parikh
    Organization Department of Psychiatry, UNC Chapel Hill
    Phone 919-966-9929
    Email jhana_parikh@med.unc.edu
    Responsible Party:
    University of North Carolina, Chapel Hill
    ClinicalTrials.gov Identifier:
    NCT03178344
    Other Study ID Numbers:
    • 16-1911a
    • R01MH111889-01
    First Posted:
    Jun 6, 2017
    Last Update Posted:
    Feb 26, 2019
    Last Verified:
    Feb 1, 2018